15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for ULBI yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $5.46 current
Highest Target—
Average Target—
Lowest Target—
ULBI analyst recommendation trends
86420
Jul
Aug
Sep
Oct
Strong BuyBuyHoldSellStrong Sell
RATING
JUL
AUG
SEP
OCT
Strong Buy
0
0
0
0
Buy
1
1
1
1
Hold
0
0
0
0
Sell
0
0
0
0
Strong Sell
0
0
0
0
Total
1
1
1
1
As of Oct, 1 of 1 firms rate ULBI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
Top analysts covering Ultralife Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ULBI.
#1
Josh Sullivan
Benchmark · Rank #17
Buy
$14.00+156.4% to target
Overall win rate
54%
+ Follow
#2
JS
Josh Sullivan
JonesTrading
Buy
$14.00+156.4% to target
Coverage
—
+ Follow
ULBI stock forecast FAQ
Who is the most accurate analyst covering ULBI?+
Among analysts who currently cover ULBI, Josh Sullivan of Benchmark has the strongest overall Quantellect track record (Rank #17). Their current call is Buy with a $14.00 target.
Have analysts been upgrading or downgrading ULBI lately?+
As of Oct, 1 of 1 firms rate ULBI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ULBI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
